Randomized Controlled Trial of Labetalol Versus Hydralazine for Severe Hypertension in Obstetric Patients.

Clinical trial NCT02050529 · COMPLETED

Trial details

NCT number: NCT02050529
Sponsor: Dow University of Health Sciences
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hypertension, Pregnancy Induced Hydralazine Adverse Reaction Pre-eclampsia Pre-eclampsia Superimposed Pre-existing Hypertension

Start date: 2012-10-01
Primary completion: 2014-09-01
Enrollment: 190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.